Quadrature Capital Ltd increased its position in Maximus, Inc. (NYSE:MMS – Free Report) by 6.0% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 10,934 shares of the health services provider’s stock after buying an additional 621 shares during the quarter. Quadrature Capital Ltd’s holdings in Maximus were worth $1,018,000 at the end of the most recent reporting period.
A number of other institutional investors have also bought and sold shares of MMS. Dimensional Fund Advisors LP lifted its position in shares of Maximus by 7.4% in the second quarter. Dimensional Fund Advisors LP now owns 1,153,977 shares of the health services provider’s stock valued at $98,904,000 after acquiring an additional 79,092 shares in the last quarter. Van Berkom & Associates Inc. raised its stake in Maximus by 0.8% during the 2nd quarter. Van Berkom & Associates Inc. now owns 1,146,524 shares of the health services provider’s stock valued at $98,257,000 after purchasing an additional 8,811 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in Maximus by 12.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider’s stock worth $86,552,000 after purchasing an additional 102,350 shares in the last quarter. Assenagon Asset Management S.A. boosted its stake in Maximus by 277.0% in the 3rd quarter. Assenagon Asset Management S.A. now owns 878,894 shares of the health services provider’s stock worth $81,878,000 after purchasing an additional 645,760 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its holdings in Maximus by 1.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 705,400 shares of the health services provider’s stock valued at $65,715,000 after buying an additional 8,667 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.
Wall Street Analysts Forecast Growth
Separately, StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a report on Thursday, November 28th.
Maximus Stock Down 1.5 %
MMS opened at $72.70 on Friday. The company has a market capitalization of $4.38 billion, a PE ratio of 14.54 and a beta of 0.73. The firm has a 50-day simple moving average of $84.71 and a two-hundred day simple moving average of $87.13. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59. Maximus, Inc. has a 52 week low of $71.75 and a 52 week high of $93.97.
Maximus Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Saturday, November 30th. Shareholders of record on Friday, November 15th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend was Friday, November 15th. Maximus’s dividend payout ratio is presently 24.00%.
Insiders Place Their Bets
In other news, insider Michelle F. Link sold 2,208 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the completion of the transaction, the insider now directly owns 6,567 shares in the company, valued at approximately $484,841.61. This represents a 25.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.40% of the company’s stock.
Maximus Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
- Five stocks we like better than Maximus
- Do ETFs Pay Dividends? What You Need to Know
- Fast-Growing Companies That Are Still Undervalued
- Canadian Penny Stocks: Can They Make You Rich?
- Top Cybersecurity Stock Picks for 2025
- 3 Best Fintech Stocks for a Portfolio Boost
- Archer or Joby: Which Aviation Company Might Rise Fastest?
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.